Altered phosphorylation and calcium sensitivity of cardiac myofibrillar proteins during sepsis

Am J Physiol Regul Integr Comp Physiol. 2001 Aug;281(2):R408-16. doi: 10.1152/ajpregu.2001.281.2.R408.

Abstract

Altered phosphorylation and Ca(2+) sensitivity of cardiac myofibrillar proteins during different phases of sepsis were investigated. Sepsis was induced by cecal ligation and puncture (CLP). The results show that phosphorylation of troponin I (TnI) was increased by 268% during the early phase (9 h after CLP) but decreased by 46% during the late phase (18 h after CLP) of sepsis. Phosphorylation of C protein was increased by 76% during the early phase but decreased by 41% during the late phase of sepsis. Phosphorylation of myosin light chain-2 (MLC-2) remained unaltered during the early phase but was decreased by 38% during the late phase of sepsis. Phosphorylation of TnT was unaffected during the progression of sepsis. The increases in the phosphorylation of TnI and C protein during early sepsis were associated with the decrease in the Ca(2+) sensitivity of myofilaments and the increases in myocardial changes in tension development (+dP/dt(max)) and cAMP level. The decreases in the phosphorylation of TnI and C protein during late sepsis coincided with the declines in the activities of myofibrillar ATPase, Ca(2+) sensitivity of myofilaments, myocardial +/-dP/dt(max), and cAMP content. The increases and the decreases in the phosphorylation of TnI and C protein, +/-dP/dt(max), and the tissue cAMP level were sensitive to isoproterenol stimulation and propranolol inhibition. These findings suggest that alterations in the phosphorylation of myofibrillar proteins, such as TnI, C protein, and MLC-2, and changes in the activities and the Ca(2+) sensitivity of myofibrillar ATPase may contribute to the altered cardiac function during the progression of sepsis. Furthermore, the sepsis-induced alterations in the phosphorylation and Ca(2+) sensitivity of cardiac myofibrillar proteins were mediated via a beta-adrenergic receptor pathway.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenosine Triphosphatases / metabolism
  • Adrenergic beta-Agonists / pharmacology
  • Animals
  • Biomarkers
  • Calcium / metabolism*
  • Cardiac Myosins*
  • Carrier Proteins / metabolism
  • Heart / drug effects
  • Heart / physiology
  • Isoproterenol / pharmacology
  • Male
  • Myocardial Contraction / physiology
  • Myocardium / chemistry
  • Myocardium / cytology
  • Myocardium / metabolism*
  • Myofibrils / chemistry
  • Myofibrils / metabolism*
  • Myosin Light Chains / metabolism
  • Phosphorylation
  • Rats
  • Rats, Sprague-Dawley
  • Sepsis / metabolism*
  • Sepsis / physiopathology
  • Tissue Extracts / chemistry
  • Tissue Extracts / metabolism
  • Troponin I / metabolism*
  • Troponin T / metabolism

Substances

  • Adrenergic beta-Agonists
  • Biomarkers
  • Carrier Proteins
  • Myosin Light Chains
  • Tissue Extracts
  • Troponin I
  • Troponin T
  • citrate-binding transport protein
  • myosin light chain 2
  • Adenosine Triphosphatases
  • Cardiac Myosins
  • Isoproterenol
  • Calcium